As of Dec 15
| -0.27 / -1.98%|
The 4 analysts offering 12-month price forecasts for Nightstar Therapeutics PLC have a median target of 27.00, with a high estimate of 30.00 and a low estimate of 25.00. The median estimate represents a +101.64% increase from the last price of 13.39.
The current consensus among 4 polled investment analysts is to Buy stock in Nightstar Therapeutics PLC. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.